Notícias e Atividades da NGM Biopharmaceuticals

NGM Biopharmaceuticals é uma empresa listada sob o símbolo NGM (US).

Veja o organograma con seus 40 executivos principais

Biografias mais buscadas da NGM Biopharmaceuticals

• Diana Peng Bockus, Chief Executive Officer
• Shelly Guyer, Director
• William Rieflin, Chairman of the Board

Criar um alerta
para seguir os movimentos de executivos da NGM Biopharmaceuticals.

NGM Biopharmaceuticals possui 2.405 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e BioNTech (Alemanha).

Popular M&A news in Biotecnologia

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (publicado em 4 de junho de 2026).
• Oak Hill Bio acaba de anunciar uma arrecadação de fundos de 33 milhões de dólares. (publicado em 4 de junho de 2026).
• IMU Biosciences acaba de anunciar uma arrecadação de fundos de 53 milhões de dólares. (publicado em 3 de junho de 2026).

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Valerie Hanote - Non-Executive Director da Eurofins

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de NGM Biopharmaceuticals

• NGM Bio Appoints Siobhan Nolan Mangini to President and Chief Financial Officer | NGM Biopharmaceuticals, Inc.
• NGM Bio to Host the Final of Four Virtual R&D Events on June 29, 2022 | NGM Biopharmaceuticals, Inc.
• NGM Bio to Participate in Upcoming Investor Conferences | NGM Biopharmaceuticals, Inc.
• NGM Bio to Host the Third of Four Virtual R&D Events on May 31, 2022 | NGM Biopharmaceuticals, Inc.
• NGM Bio Announces Initiation of Phase 1/1b Clinical Study of NGM438 for the Treatment of Patients with Advanced Solid Tumors | NGM Biopharmaceuticals, Inc.
• NGM Bio Provides Business Highlights and Reports First Quarter 2022 Financial Results | NGM Biopharmaceuticals, Inc.
• News | NGM Biopharmaceuticals, Inc.
• News | NGM Biopharmaceuticals, Inc.
• NGM Bio to Participate in Upcoming Investor Conferences | NGM Biopharmaceuticals, Inc.
• NGM Bio to Host the Second of Four Virtual R&D Events on April 27, 2022 | NGM Biopharmaceuticals, Inc.
• View more press releases Close

Redes sociais sobre NGM Biopharmaceuticals

• NGM Biopharmaceuticals na Wikipedia, Google News e Yahoo Finance
• NGM Biopharmaceuticals na LinkedIn, X (Twitter) e YouTube